192 related articles for article (PubMed ID: 6910482)
1. Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit.
Wiggins RC; Giclas PC; Henson PM
J Exp Med; 1981 Jun; 153(6):1391-404. PubMed ID: 6910482
[TBL] [Abstract][Full Text] [Related]
2. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of the fifth component of human complement and release of a split product with C5a-like activity by crystalline silica through free radical generation and kallikrein activation.
Governa M; Fenoglio I; Amati M; Valentino M; Bolognini L; Coloccini S; Volpe AR; Carmignani M; Fubini B
Toxicol Appl Pharmacol; 2002 Mar; 179(3):129-36. PubMed ID: 11906242
[TBL] [Abstract][Full Text] [Related]
4. Human C5a and C5a analogs as probes of the neutrophil C5a receptor.
Chenoweth DE; Hugli TE
Mol Immunol; 1980 Feb; 17(2):151-61. PubMed ID: 6248769
[No Abstract] [Full Text] [Related]
5. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.
Kaplan AP; Kay AB; Austen KF
J Exp Med; 1972 Jan; 135(1):81-97. PubMed ID: 5009705
[TBL] [Abstract][Full Text] [Related]
6. Significance of Hageman factor (coagulation factor XII) for neutrophil locomotion and chemotaxis.
Keller HU; Beck EA; Hess MW; Cottier H
Int Arch Allergy Appl Immunol; 1977; 55(1-6):309-13. PubMed ID: 591099
[TBL] [Abstract][Full Text] [Related]
7. Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5.
Orr W; Phan SH; Varani J; Ward PA; Kreutzer DL; Webster RO; Henson PM
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1986-9. PubMed ID: 287038
[TBL] [Abstract][Full Text] [Related]
8. Variability of biological effects of silicas: different degrees of activation of the fifth component of complement by amorphous silicas.
Governa M; Amati M; Fenoglio I; Valentino M; Coloccini S; Bolognini L; Carlo Botta G; Emanuelli M; Pierella F; Volpe AR; Astolfi P; Carmignani M; Fubini B
Toxicol Appl Pharmacol; 2005 Oct; 208(1):68-77. PubMed ID: 16164962
[TBL] [Abstract][Full Text] [Related]
9. [Plasma kallikrein: new functions].
Paskhina TS
Biokhimiia; 1976 Aug; 41(8):1347-51. PubMed ID: 1030643
[TBL] [Abstract][Full Text] [Related]
10. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
Meier HL; Pierce JV; Colman RW; Kaplan AP
J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
[TBL] [Abstract][Full Text] [Related]
11. In vitro cleavage by asbestos fibers of the fifth component of human complement through free-radical generation and kallikrein activation.
Governa M; Amati M; Valentino M; Visonà I; Fubini B; Botta GC; Volpe AR; Carmignani M
J Toxicol Environ Health A; 2000 Apr; 59(7):539-52. PubMed ID: 10777245
[TBL] [Abstract][Full Text] [Related]
12. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
[TBL] [Abstract][Full Text] [Related]
13. Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein.
Cochrane CG; Revak SD; Wuepper KD
J Exp Med; 1973 Dec; 138(6):1564-83. PubMed ID: 4271629
[TBL] [Abstract][Full Text] [Related]
14. Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis.
Ernst JD; Hartiala KT; Goldstein IM; Sande MA
Infect Immun; 1984 Oct; 46(1):81-6. PubMed ID: 6480117
[TBL] [Abstract][Full Text] [Related]
15. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
Kaplan AP
Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
[TBL] [Abstract][Full Text] [Related]
16. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
Saito H; Ratnoff OD
J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
[TBL] [Abstract][Full Text] [Related]
17. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships.
Kaplan AP; Ghebrehiwet B; Silverberg M; Sealey JE
Crit Rev Immunol; 1981 Sep; 3(1):75-93. PubMed ID: 7047077
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the regulation of complement-derived chemotactic factors in blunt trauma.
Maderazo EG; Moore M; Woronick CL
J Infect Dis; 1988 Feb; 157(2):364-7. PubMed ID: 3335811
[No Abstract] [Full Text] [Related]
19. Neutrophil-mediated tumor cell destruction in cancer ascites. II. A OK-432 attracts killer neutrophils through activation of complement C5.
Fujimura T; Torisu M
Clin Immunol Immunopathol; 1987 May; 43(2):174-84. PubMed ID: 3105938
[TBL] [Abstract][Full Text] [Related]
20. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
Weiss AS; Gallin JI; Kaplan AP
J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
